Washington D.C., District of Columbia
CNS clinical trials in Washington D.C., DC
33 CNS studies are recruiting participants at sites in Washington D.C. as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Washington D.C. at a glance
- 33 studies are recruiting at a site in Washington D.C..
- By phase: Phase 1 (4), Phase 2 (1), Phase 3 (15), No phase (8), Observational (5). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (18), university, hospital or other (14), government (1).
- By research area: Depression (7), Multiple Sclerosis (7), Migraine (6), Parkinson's Disease (6), Epilepsy (3), ADHD (2), Schizophrenia (2).
- Most recent update to one of these records: November 12, 2026.
Depression studies recruiting in Washington D.C.
Basic details from each study's public record (the 30 most recently updated of 33). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Kaiser Permanente-Capitol Hill Medical Center · MedStar Georgetown University Hospital · MedStar Washington Hospital Center
- Registry record
- NCT06748222 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Children's National Medical Center
- Registry record
- NCT07227454 · updated
Mindful Self-Compassion for Anxiety Disorders and Depression
- No phase
- Ages 18 to 75
- All sexes
- Sponsor
- Georgetown University
- Study site
- Georgetown University Medical Center
- Registry record
- NCT05671419 · updated
Does Social Media Impact Adolescent Mental Health?
- No phase
- Ages 10 to 14
- All sexes
- Sponsor
- Georgetown University
- Study site
- Georgetown University
- Registry record
- NCT06049888 · updated
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
- No phase
- Ages 18 to 65
- All sexes
- Sponsor
- Georgetown University
- Study site
- Georgetown University Medical Center
- Registry record
- NCT07028216 · updated
The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic
- No phase
- All ages
- All sexes
- Sponsor
- Children's National Research Institute
- Study site
- Children's National Hospital
- Registry record
- NCT06623981 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Schizophrenia studies recruiting in Washington D.C.
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigator Site
- Registry record
- NCT05303064 · updated
BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
- No phase
- Ages 16 to 30
- All sexes
- Sponsor
- Howard University
- Study site
- Howard University Hospital
- Registry record
- NCT07417904 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Washington D.C., DC on ClinicalTrials.gov.
ADHD studies recruiting in Washington D.C.
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Study site
- Children's National Medical Center
- Registry record
- NCT03047369 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Washington D.C.
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Washington Hospital Center ( Site 0098)
- Registry record
- NCT06841354 · updated
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- MedStar Washington Hospital Center ( Site 5005)
- Registry record
- NCT06952504 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Georgetown University
- Registry record
- NCT07174310 · updated
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Phase 3
- Ages 45 to 75
- All sexes
- Sponsor
- BlueRock Therapeutics
- Study site
- MedStar Georgetown University Hospital
- Registry record
- NCT06944522 · updated
RESvEraTrol in Parkinson's Disease (RESET)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Georgetown University
- Study site
- Georgetown University Hospital
- Registry record
- NCT07592767 · updated
Social & QoL Behaviors in Parkinson's Disease
- Observational
- Ages 40 and older
- All sexes
- Sponsor
- Gregory Wallace
- Study site
- The George Washington University
- Registry record
- NCT06385184 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Washington D.C.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- MedStar Georgetown University Hospital
- Registry record
- NCT03816345 · updated
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06433752 · updated
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Phase 3
- Ages 40 to 70
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Medstar Washington Hospital Center
- Registry record
- NCT06846281 · updated
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT05877963 · updated
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study sites
- Georgetown University Hospital · Medstar Washington Hosp Ctr
- Registry record
- NCT07225504 · updated
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Phase 1
- Ages 18 to 60
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT07224373 · updated
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Study site
- Georgetown University Hospital Pasquerilla Healthcare Center
- Registry record
- NCT06665165 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Epilepsy studies recruiting in Washington D.C.
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Neurona Therapeutics
- Study site
- George Washington University
- Registry record
- NCT05135091 · updated
Artificial Intelligence for Brain MRI Analysis in Epilepsy
- Observational
- All ages
- All sexes
- Sponsor
- Istituto Giannina Gaslini
- Study site
- George Washington University
- Registry record
- NCT07881185 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Migraine studies recruiting in Washington D.C.
Dietary Intervention for Migraine Relief
- No phase
- Ages 18 to 75
- All sexes
- Sponsor
- American University
- Study site
- American University
- Registry record
- NCT07360405 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Children's National Medical Center
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Children's National Medical Center
- Registry record
- NCT04743141 · updated
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Velocity Clinical Research, Washington DC
- Registry record
- NCT05156398 · updated
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Phase 1
- Ages 6 to 11
- All sexes
- Sponsor
- Pfizer
- Study site
- Velocity Clinical Research, Washington DC
- Registry record
- NCT06995729 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Emerson Clinical Research Institute - Connecticut Avenue - Washington /ID# 231693
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Washington D.C., DC on ClinicalTrials.gov.
Ask about studies near Washington D.C.
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections